Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Urba

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Immunological monitoring and clinical trials of biological response modifiersM W Baseler, W J Urba
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Immunological monitoring and clinical trials of biological response modifiersW J Urba, M W Baseler
Seminars in Oncology|September 1, 1985
Cytologic, immunologic, and clinical diversity in non-Hodgkin's lymphoma: therapeutic implicationsW J Urba, D L Longo
Investigative Radiology|August 1, 1993
Hodgkin's disease in adults. Part IW J Urba, D L Longo
The New England Journal of Medicine|March 5, 1992
Hodgkin's diseaseW J Urba, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Adoptive cellular therapyW J Urba, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Adoptive cellular therapyW J Urba, D L Longo
Investigative Radiology|September 1, 1993
Hodgkin's disease in adults. Part IIW J Urba, D L Longo
Journal of the National Cancer Institute|March 17, 1993
Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15M Beckwith, W J Urba, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
Immunological monitoring and clinical trials of biological response modifiersM W Baseler, W C Kopp, W J Urba
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Immunological monitoring and clinical trials of biological response modifiersM W Baseler, W J Urba
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Immunological monitoring and clinical trials of biological response modifiersW J Urba, M W Baseler
Seminars in Oncology|September 1, 1985
Cytologic, immunologic, and clinical diversity in non-Hodgkin's lymphoma: therapeutic implicationsW J Urba, D L Longo
Investigative Radiology|August 1, 1993
Hodgkin's disease in adults. Part IW J Urba, D L Longo
The New England Journal of Medicine|March 5, 1992
Hodgkin's diseaseW J Urba, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Adoptive cellular therapyW J Urba, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Adoptive cellular therapyW J Urba, D L Longo
Investigative Radiology|September 1, 1993
Hodgkin's disease in adults. Part IIW J Urba, D L Longo
Journal of the National Cancer Institute|March 17, 1993
Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15M Beckwith, W J Urba, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
Immunological monitoring and clinical trials of biological response modifiersM W Baseler, W C Kopp, W J Urba
Pageof 11